MRK SEC Filing News — Merck & Company, Inc.

Latest SEC filings for Merck & Company, Inc. (MRK) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). All data sourced directly from SEC EDGAR — last updated 2026-07-01.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health manageme…
Sector: Healthcare Industry: Drug Manufacturers - General CIK: 310158
20
Total Filings
0
Bullish Signals
0
Bearish Signals
18
Insider Transactions
2
Material Events (8-K)
0
Periodic Reports
What you're looking at: Each item below is parsed from an actual SEC filing submitted by Merck & Company, Inc.. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.
MRK Filing Activity Snapshot 2026-05-07 — 2026-07-01
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Recent SEC Filings
Form 4 Tax / Compensation Filing 2026-07-01

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Seidman Christine E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Seidman Christine E (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-07-01

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Karsanbhai Surendralal Lanca (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Karsanbhai Surendralal Lanca (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-07-01

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Coe Mary Ellen (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Coe Mary Ellen (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Warden Kathy J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Warden Kathy J (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Karsanbhai Surendralal Lanca (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Karsanbhai Surendralal Lanca (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Coe Mary Ellen (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Coe Mary Ellen (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

THULIN INGE G (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: THULIN INGE G (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Seidman Christine E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Seidman Christine E (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

RUSSO PATRICIA F (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: RUSSO PATRICIA F (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Rothman Paul (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Rothman Paul (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Mayo Stephen (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Mayo Stephen (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

LAVIZZO-MOUREY RISA J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: LAVIZZO-MOUREY RISA J (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

GLOCER THOMAS H (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: GLOCER THOMAS H (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Craig Pamela J. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Craig Pamela J. (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-06-02

MRK insider Form 4 filed for equity award, exercise, or tax withholding

BAKER DOUGLAS M JR (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: BAKER DOUGLAS M JR (Director)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-28

MRK filed 8-K — material company event

Merck & Co., Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-22

MRK filed 8-K — material company event

Merck & Co., Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-07

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Zachary Jennifer (EVP, General Counsel) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Zachary Jennifer (EVP, General Counsel)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-07

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Williams David Michael (EVP,Chief Info&Digital Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Williams David Michael (EVP,Chief Info&Digital Officer)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-07

MRK insider Form 4 filed for equity award, exercise, or tax withholding

Litchfield Caroline (EVP & CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Litchfield Caroline (EVP & CFO)
View on SEC EDGAR → Open Filing Document →

Understanding Merck & Company, Inc.'s SEC Filings

Form 4 — Insider Transactions

Executives, directors, and large shareholders must report any purchase or sale of MRK shares within two business days. Consistent buying by multiple insiders is often read as a confidence signal; large sales may reflect diversification or liquidity needs rather than negative conviction.

Form 144 — Proposed Insider Sales

Filed when a company affiliate intends to sell restricted or control shares. A Form 144 is a notice of intent, not confirmation — the actual sale is later confirmed via Form 4. It gives investors advance visibility into planned insider selling activity.

8-K — Material Events

The 8-K is an event-driven filing that Merck & Company, Inc. must submit within four business days of a significant development — including earnings results, mergers, executive changes, credit facility updates, or regulatory actions. Each 8-K item code maps to a specific event type.

10-Q & 10-K — Periodic Reports

The 10-Q (quarterly) and 10-K (annual) are comprehensive reports covering Merck & Company, Inc.'s financial results, risk factors, management discussion, and business operations. The 10-K includes audited financials and is the most complete public disclosure the company makes each year.

Frequently Asked Questions — MRK SEC Filings

What SEC filings does Merck & Company, Inc. submit to the SEC?

Merck & Company, Inc. (MRK) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about MRK?

A Form 4 for MRK discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the date, number of shares bought or sold, the price, and the insider's updated total ownership. Consistent insider buying across multiple executives is often interpreted as a bullish signal.

How do I interpret an 8-K filing from Merck & Company, Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for MRK?

The 10-K is Merck & Company, Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all MRK SEC filings directly on EDGAR?

You can view all historical Merck & Company, Inc. filings on the SEC EDGAR company page for MRK. Each filing card on this page links directly to the original SEC document.

How often does Merck & Company, Inc. file with the SEC?

Merck & Company, Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling MRK shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

More Tools for MRK

MRK Full Stock Analysis MRK Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Demand Zone Analyzer Sector Scanner Browse All Stocks

Want deeper MRK analysis?

View valuation, growth metrics, AI Strong Buy score, demand zones, peer comparison, and more — all on the MRK stock analysis page.

MRK Full Analysis
SEC filing data is sourced from SEC EDGAR. This page is updated automatically as new filings are detected. Content is for informational purposes only and does not constitute investment advice. Full Disclaimer.